Clinical Trial Update: Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies [Phase 2]

View source ↗

Summary

Phase 2 open-label trial of ganaxolone in children with PCDH19 female pediatric epilepsy and other rare genetic epilepsies completed with results posted in 2022…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• ganaxolone (ganaxolone)

Snippet

Sponsor: Marinus Pharmaceuticals | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2022-09-07